National Center for Complementary & Integrative Health; Notice of Meeting, 75641 [2022-26833]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 236 / Friday, December 9, 2022 / Notices
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–26846 Filed 12–8–22; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: December 6, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2022–26832 Filed 12–8–22; 8:45 am]
BILLING CODE 4140–01–P
National Institute on Drug Abuse;
Notice of Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Avenir
Award Program for Genetics or Epigenetics of
Substance Use Disorders.
Date: February 15, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ipolia R Ramadan, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, MSC 6021,
Bethesda, MD 20892, (301) 827–4471,
ramadanir@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Avenir
Award Program for Genetics or Epigenetics of
Substance Use Disorders.
Date: February 17, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ipolia R Ramadan, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, MSC 6021,
Bethesda, MD 20892, (301) 827–4471,
ramadanir@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
VerDate Sep<11>2014
17:50 Dec 08, 2022
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Complementary and
Integrative Health.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
The meeting will be open to the
public as indicated below and held as
a virtual meeting. Individuals who plan
to view the virtual meeting and need
special assistance or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting. The open session can be
accessed at the following NIH Videocast
URL link https://videocast.nih.gov.
Name of Committee: National Advisory
Council for Complementary and Integrative
Health.
Date: January 20, 2023.
Closed: 10:00 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy 2, 6707 Democracy Boulevard,
Bethesda, MD 20817, (Virtual Meeting).
Open: 11:40 a.m. to 5:00 p.m.
Agenda: A report from the Director of the
Center and Other Staff.
Place: National Institutes of Health,
Democracy 2, 6707 Democracy Boulevard,
Bethesda, MD 20817, (Virtual Meeting).
Contact Person: Martina Schmidt, Ph.D.,
Director, Division of Extramural Activities,
National Center for Complementary &
Integrative Health, NIH, 6707 Democracy
Blvd., Suite 401, Bethesda, MD 20892, (301)
594–3456, schmidma@mail.nih.gov.
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
75641
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person. Any
member of the public may submit written
comments no later than 15 days after the
meeting.
Information is also available on the
Institute’s/Center’s home page: https://
www.nccih.nih.gov/news/events/advisorycouncil-83rd-meeting, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: December 6, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–26833 Filed 12–8–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–0022–0047; OMB No.
1660–0118]
Agency Information Collection
Activities: Proposed Collection;
Comment Request; Homeland Security
Exercise and Evaluation Program
(HSEEP) Documentation
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: 60-Day notice of revision and
request for comments.
AGENCY:
The Federal Emergency
Management Agency (FEMA), as part of
its continuing effort to reduce
paperwork and respondent burden,
invites the general public to take this
opportunity to comment on an
extension, with change, of a currently
approved information collection. In
accordance with the Paperwork
Reduction Act of 1995, this notice seeks
comments concerning the After Action
Report/Improvement Plans, Integrated
Preparedness Plans, and Support
Request Forms to the National Exercise
Program which are used to validate
current preparedness capabilities and
support future national exercise efforts.
DATES: Comments must be submitted on
or before February 7, 2023.
ADDRESSES: To avoid duplicate
submissions to the docket, please
submit comments at
SUMMARY:
E:\FR\FM\09DEN1.SGM
09DEN1
]]>Agencies
[Federal Register Volume 87, Number 236 (Friday, December 9, 2022)]
[Notices]
[Page 75641]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-26833]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Integrative Health; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council for Complementary and Integrative Health.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
The meeting will be open to the public as indicated below and held
as a virtual meeting. Individuals who plan to view the virtual meeting
and need special assistance or other reasonable accommodations, should
notify the Contact Person listed below in advance of the meeting. The
open session can be accessed at the following NIH Videocast URL link
https://videocast.nih.gov.
Name of Committee: National Advisory Council for Complementary
and Integrative Health.
Date: January 20, 2023.
Closed: 10:00 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Democracy 2, 6707
Democracy Boulevard, Bethesda, MD 20817, (Virtual Meeting).
Open: 11:40 a.m. to 5:00 p.m.
Agenda: A report from the Director of the Center and Other
Staff.
Place: National Institutes of Health, Democracy 2, 6707
Democracy Boulevard, Bethesda, MD 20817, (Virtual Meeting).
Contact Person: Martina Schmidt, Ph.D., Director, Division of
Extramural Activities, National Center for Complementary &
Integrative Health, NIH, 6707 Democracy Blvd., Suite 401, Bethesda,
MD 20892, (301) 594-3456, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person. Any member of the public may
submit written comments no later than 15 days after the meeting.
Information is also available on the Institute's/Center's home
page: https://www.nccih.nih.gov/news/events/advisory-council-83rd-meeting, where an agenda and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.213,
Research and Training in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: December 6, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-26833 Filed 12-8-22; 8:45 am]
BILLING CODE 4140-01-P
